loadpatents
name:-0.082446098327637
name:-0.037986993789673
name:-0.038298845291138
Pomper; Martin G. Patent Filings

Pomper; Martin G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pomper; Martin G..The latest application filed is for "administration of therapeutic agents to brain and other cells and tissue".

Company Profile
40.41.81
  • Pomper; Martin G. - Baltimore MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Administration Of Therapeutic Agents To Brain And Other Cells And Tissue
App 20220296736 - Janowski; Miroslaw ;   et al.
2022-09-22
Psma-targeting Compounds And Uses Thereof
App 20220259161 - Pomper; Martin G. ;   et al.
2022-08-18
Metal/radiometal-labeled Psma Inhibitors For Psma-targeted Imaging And Radiotherapy
App 20220135529 - Ray; Sangeeta ;   et al.
2022-05-05
Psma-binding Agents And Uses Thereof
App 20220088229 - Pomper; Martin G. ;   et al.
2022-03-24
Synthesis Of The Radiolabeled Prostate-specific Membrane Antigen (psma) Inhibitor [18f]dcfpyl
App 20220055991 - Ravert; Hayden T. ;   et al.
2022-02-24
Psma-targeted Pamam Dendrimers For Specific Delivery Of Imaging, Contrast And Therapeutic Agents
App 20220054659 - Pomper; Martin G. ;   et al.
2022-02-24
Psma Targeted Fluorescent Agents For Image Guided Surgery
App 20220048872 - Pomper; Martin G. ;   et al.
2022-02-17
Compositions of nucleic acid-containing nanoparticles for in vivo delivery
Grant 11,235,071 - Mao , et al. February 1, 2
2022-02-01
Competitive Prostate-specific Membrane Antigen (psma) Binding Agents For Reduction Of Non-target Organ Uptake Of Radiolabeled Psma Inhibitors For Psma Positive Tumor Imaging And Radiopharmaceutical Therapy
App 20210338846 - Pomper; Martin G. ;   et al.
2021-11-04
Inhibition Of Rip Kinases For Treating Neurodegenerative Disorders
App 20210322427 - LEE; Seulki ;   et al.
2021-10-21
Long-circulating Psma-targeted Phototheranostic Agent
App 20210308286 - Pomper; Martin G. ;   et al.
2021-10-07
Positron Emission Tomography (pet) Radiotracers For Imaging Macrophage Colony-stimulating Factor 1 Receptor (csf1r) In Neuroinflammation
App 20210290784 - Horti; Andrew G. ;   et al.
2021-09-23
PSMA-based molecular-genetic reporter system
Grant 11,124,845 - Pomper , et al. September 21, 2
2021-09-21
Compositions and methods for treating pancreatitis and pain with death receptor agonists
Grant 11,084,879 - Lee , et al. August 10, 2
2021-08-10
Triazole conjugated ureas, thioureas, carbamates, and reversed carbamates for PSMA-targeted imaging agents and uses thereof
Grant 11,078,166 - Pomper , et al. August 3, 2
2021-08-03
Psma Targeted Radiohalogenated Urea-polyaminocarboxylates For Cancer Radiotherapy
App 20210220493 - Pomper; Martin G. ;   et al.
2021-07-22
PSMA targeted fluorescent agents for image guided surgery
Grant 11,021,450 - Pomper , et al. June 1, 2
2021-06-01
Ameliorating systemic sclerosis with death receptor agonists
Grant 11,007,251 - Lee , et al. May 18, 2
2021-05-18
Synthesis of the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor [.sup.18F]DCFPyL
Grant 10,947,197 - Ravert , et al. March 16, 2
2021-03-16
68Ga-LABELED NOTA-CHELATED PSMA-TARGETED IMAGING AND THERAPEUTIC AGENTS
App 20210040126 - Pomper; Martin G. ;   et al.
2021-02-11
.sup.18F-FNDP for pet imaging of soluble epoxide hydrolase (sEH)
Grant 10,912,850 - Horti , et al. February 9, 2
2021-02-09
PAMAM dendrimer based CEST imaging agents and uses thereof
Grant 10,898,594 - Lesniak , et al. January 26, 2
2021-01-26
Nuclear imaging and radiotherapeutics agents targeting carbonic anhydrase IX and uses thereof
Grant 10,857,246 - Yang , et al. December 8, 2
2020-12-08
Scaffolds And Multifunctional Intermediates For Imaging Psma And Cancer Therapy
App 20200360542 - Pomper; Martin G. ;   et al.
2020-11-19
Psma-based Molecular-genetic Reporter System
App 20200347464 - Pomper; Martin G. ;   et al.
2020-11-05
Imaging And Radiotherapeutics Agents Targeting Fibroblast-activation Protein-alpha (fap-alpha)
App 20200330624 - Yang; Xing ;   et al.
2020-10-22
Salicylic Acid-based Polymeric Cest Contrast Agents Targeting Prostate-specific Membrane Antigen And Uses Thereof
App 20200330613 - Ray; Sangeeta ;   et al.
2020-10-22
Prostate-specific Membrane Antigen Targeted High-affinity Agents For Endoradiotherapy Of Prostate Cancer
App 20200306391 - Ray; Sangeeta ;   et al.
2020-10-01
Glucose Conjugates Of Triptolide, Analogs And Uses Thereof
App 20200297693 - LIU; JUN ;   et al.
2020-09-24
Metal/radiometal-labeled Psma Inhibitors For Psma-targeted Imaging And Radiotherapy
App 20200290982 - Ray; Sangeeta ;   et al.
2020-09-17
Psma-binding Agents And Uses Thereof
App 20200282083 - Pomper; Martin G. ;   et al.
2020-09-10
Psma Targeted Fluorescent Agents For Image Guided Surgery
App 20200283412 - Pomper; Martin G. ;   et al.
2020-09-10
Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy
Grant 10,736,974 - Pomper , et al. A
2020-08-11
Psma Targeted Radiohalogenated Ureas For Cancer Radiotherapy
App 20200231614 - POMPER; MARTIN G. ;   et al.
2020-07-23
68Ga-labeled NOTA-chelated PSMA-targeted imaging and therapeutic agents
Grant 10,717,750 - Pomper , et al.
2020-07-21
Psma Targeted Fluorescent Agents For Image Guided Surgery
App 20200216402 - Pomper; Martin G. ;   et al.
2020-07-09
Glucose conjugates of triptolide, analogs and uses thereof
Grant 10,695,319 - Liu , et al.
2020-06-30
Salicylic acid-based polymeric CEST contrast agents targeting prostate-specific membrane antigen and uses thereof
Grant 10,688,198 - Ray , et al.
2020-06-23
Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy
Grant 10,683,272 - Ray , et al.
2020-06-16
Prostate Specific Membrane Antigen (psma) Targeted Nanoparticles For Therapy Of Prostate Cancer
App 20200170960 - Chandran; Sachin S. ;   et al.
2020-06-04
Prostate-specific Membrane Antigen Targeted High-affinity Agents For Endoradiotherapy Of Prostate Cancer
App 20200155713 - RAY; SANGEETA ;   et al.
2020-05-21
Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
Grant 10,653,806 - Pomper , et al.
2020-05-19
Transcriptionally Targeted And Cpg-free Plasmid For Theranostic Gene Therapy
App 20200140831 - Green; Jordan J. ;   et al.
2020-05-07
Psma Targeted Fluorescent Agents For Image Guided Surgery
App 20200109124 - Pomper; Martin G. ;   et al.
2020-04-09
PSMA-binding agents and uses thereof
Grant 10,500,292 - Pomper , et al. Dec
2019-12-10
Development Of New Monoclonal Antibodies Recognizing Human Prostate-specific Membrane Antigen (psma)
App 20190330367 - Barinka; Cyril ;   et al.
2019-10-31
Collagen mimetic peptides for targeting collagen strands for in vitro and in vivo imaging and therapeutic use
Grant 10,426,850 - Yu , et al. October 1, 2
2019-10-01
Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
Grant 10,413,620 - Pomper , et al. Sept
2019-09-17
Light-Emitting Versions of the Monoclonal Antibody to C3D (MAB 3D29) for Imaging
App 20190240355 - Pomper; Martin G. ;   et al.
2019-08-08
Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer
Grant 10,369,113 - Chandran , et al.
2019-08-06
Triazole Conjugated Ureas, Thioureas, Carbamates, And Reversed Carbamates For Psma-targeted Imaging Agents And Uses Thereof
App 20190225589 - POMPER; MARTIN G. ;   et al.
2019-07-25
Nuclear Imaging And Radiotherapeutics Agents Targeting Carbonic Anhydrase Ix And Uses Thereof
App 20190192699 - YANG; Xing ;   et al.
2019-06-27
Improved Synthesis Of The Radiolabeled Prostate-specific Membrane Antigen (psma) Inhibitor [18f]dcfpyl
App 20190177275 - Ravert; Hayden T. ;   et al.
2019-06-13
18F-FNDP FOR PET IMAGING OF SOLUBLE EPOXIDE HYDROLASE (sEH)
App 20190134235 - HORTI; ANDREW ;   et al.
2019-05-09
Compositions And Methods For Treating Pancreatitis And Pain With Death Receptor Agonists
App 20190119394 - Lee; Seulki ;   et al.
2019-04-25
Prostate-specific membrane antigen-targeted photosensitizers for photodynamic therapy
Grant 10,232,058 - Pomper , et al.
2019-03-19
Pamam Dendrimer Based Cest Imaging Agents And Uses Thereof
App 20190060490 - LESNIAK; WOJCIECH ;   et al.
2019-02-28
Glucose Conjugates Of Triptolide, Analogs And Uses Thereof
App 20190038596 - Liu; Jun ;   et al.
2019-02-07
Compositions and methods for chemical exchange saturation transfer (CEST) based magnetic resonance imaging (MRI)
Grant 10,188,754 - Yang , et al. Ja
2019-01-29
68Ga-LABELED NOTA-CHELATED PSMA-TARGETED IMAGING AND THERAPEUTIC AGENTS
App 20190023722 - POMPER; MARTIN G. ;   et al.
2019-01-24
Ameliorating Systemic Sclerosis With Death Receptor Agonists
App 20190000924 - Lee; Seulki ;   et al.
2019-01-03
Tripartite cancer theranostic nucleic acid constructs
Grant 10,166,300 - Fisher , et al. J
2019-01-01
Red fluorescent aldehyde dehydrogenase (ALDH) substrate
Grant 10,156,521 - Pomper , et al. Dec
2018-12-18
Salicylic Acid-based Polymeric Cest Contrast Agents Targeting Prostate-specific Membrane Antigen And Uses Thereof
App 20180264143 - RAY; SANGEETA ;   et al.
2018-09-20
Homomultivalent And Heteromultivalent Inhibitors Of Prostate Specific Membrane Antigen (psma) And Uses Thereof
App 20180236112 - POMPER; MARTIN G. ;   et al.
2018-08-23
Psma-binding Agents And Uses Thereof
App 20180236110 - POMPER; MARTIN G. ;   et al.
2018-08-23
Radiofluorinated 7-amino-5-thio-thiazolo[4,5-d]pyrimidines For Imaging Fractalkine Receptor (cx3cr1)
App 20180222922 - POMPER; MARTIN G. ;   et al.
2018-08-09
Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
Grant 10,039,845 - Pomper , et al. August 7, 2
2018-08-07
Compositions Of Nucleic Acid-containing Nanoparticles For In Vivo Delivery
App 20180177892 - MAO; HAI-QUAN ;   et al.
2018-06-28
PEG-Prom mediated surface expression of avidin/streptavidin
Grant 9,994,865 - Fisher , et al. June 12, 2
2018-06-12
Nuclear Imaging And Radiotherapeutics Agents Targeting Carbonic Anhydrase Ix And Uses Thereof
App 20180133348 - YANG; XING ;   et al.
2018-05-17
Labeled Inhibitors Of Prostate Specific Membrane Antigen (psma) Biological Evaluation, And Use Of Imaging Agents
App 20180085478 - POMPER; MARTIN G. ;   et al.
2018-03-29
Compositions And Methods For Sensitizing Cells To Trail-induced Apoptosis
App 20180050090 - Lee; Seulki ;   et al.
2018-02-22
68Ga-LABELED NOTA-CHELATED PSMA-TARGETED IMAGING AND THERAPEUTIC AGENTS
App 20180051039 - POMPER; MARTIN G. ;   et al.
2018-02-22
Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof
Grant 9,884,132 - Pomper , et al. February 6, 2
2018-02-06
Psma Targeted Fluorescent Agents For Image Guided Surgery
App 20180009767 - POMPER; MARTIN G. ;   et al.
2018-01-11
PSMA-binding agents and uses thereof
Grant 9,861,713 - Pomper , et al. January 9, 2
2018-01-09
New Scaffolds And Multifunctional Intermediates For Imaging Psma And Cancer Therapy
App 20170333576 - POMPER; MARTIN G. ;   et al.
2017-11-23
Light-Emitting Versions of the Monoclonal Antibody to C3D (MAB 3D29) for Imaging
App 20170290930 - Pomper; Martin G. ;   et al.
2017-10-12
Psma Targeted Fluorescent Agents For Image Guided Surgery
App 20170283384 - POMPER; MARTIN G. ;   et al.
2017-10-05
PSMA-targeting compounds and uses thereof
Grant 9,776,977 - Pomper , et al. October 3, 2
2017-10-03
Psma-based Molecular-genetic Reporter System
App 20170218464 - POMPER; MARTIN G. ;   et al.
2017-08-03
Imaging And Therapy Of Virus-associated Tumors
App 20170202985 - Pomper; Martin G. ;   et al.
2017-07-20
Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
Grant 9,694,091 - Pomper , et al. July 4, 2
2017-07-04
Prostate Specific Membrane Antigen (psma) Targeted Nanoparticles For Therapy Of Prostate Cancer
App 20170135961 - Chandran; Sachin S. ;   et al.
2017-05-18
Metal/radiometal-labeled Psma Inhibitors For Psma-targeted Imaging And Radiotherapy
App 20170081298 - RAY; SANGEETA ;   et al.
2017-03-23
Homomultivalent And Heteromultivalent Inhibitors Of Prostate Specific Membrane Antigen (psma) And Uses Thereof
App 20170049912 - POMPER; MARTIN G. ;   et al.
2017-02-23
Compositions And Methods Of Treating Cancer
App 20160367708 - Abraham; John Martin ;   et al.
2016-12-22
Imaging And Therapy Of Virus-associated Tumors
App 20160354498 - Pomper; Martin G. ;   et al.
2016-12-08
Compositions Of Nucleic Acid-containing Nanoparticles For In Vivo Delivery
App 20160331845 - MAO; HAI-QUAN ;   et al.
2016-11-17
Synthesis And Use Of Targeted Radiation Enhancing Iron Oxide-silica-gold Nanoshells For Imaging And Treatment Of Cancer
App 20160271274 - IVKOV; ROBERT ;   et al.
2016-09-22
Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer
Grant 9,422,234 - Chandran , et al. August 23, 2
2016-08-23
Prostate-specific Membrane Antigen-targeted Photosensitizers For Photodynamic Therapy
App 20160235865 - POMPER; MARTIN G. ;   et al.
2016-08-18
Psma-binding Agents And Uses Thereof
App 20160114060 - POMPER; Martin G. ;   et al.
2016-04-28
Peg-prom Mediated Surface Expression Of Avidin/streptavidin
App 20160108429 - FISHER; Paul B. ;   et al.
2016-04-21
Tripartite Cancer Theranostic Nucleic Acid Constructs
App 20160106866 - FISHER; Paul B. ;   et al.
2016-04-21
Compositions And Methods For Chemical Exchange Saturation Transfer (cest) Based Magnetic Resonance Imaging (mri)
App 20160082132 - YANG; XING ;   et al.
2016-03-24
Compositions And Methods For Chemical Exchange Saturation Transfer (cest) Magnetic Resonance Imaging (mri)
App 20160075667 - Yang; Xing ;   et al.
2016-03-17
TSPO-targeting compounds and uses thereof
Grant 9,233,178 - Pomper , et al. January 12, 2
2016-01-12
PSMA-binding agents and uses thereof
Grant 9,226,981 - Pomper , et al. January 5, 2
2016-01-05
Red Fluorescent Aldehyde Dehydrogenase (aldh) Substrate
App 20150369738 - POMPER; MARTIN G. ;   et al.
2015-12-24
Labeled Inhibitors Of Prostate Specific Membrane Antigen (psma) Biological Evaluation, And Use Of Imaging Agents
App 20150246144 - POMPER; MARTIN G. ;   et al.
2015-09-03
Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents
Grant 9,044,468 - Pomper , et al. June 2, 2
2015-06-02
Psma-targeting Compounds And Uses Thereof
App 20150104387 - POMPER; MARTIN G. ;   et al.
2015-04-16
Psma-binding Agents And Uses Thereof
App 20140369931 - POMPER; MARTIN G. ;   et al.
2014-12-18
Tspo-targeting Compounds And Uses Thereof
App 20140322133 - POMPER; MARTIN G. ;   et al.
2014-10-30
TSPO-targeting compounds and uses thereof
Grant 8,778,304 - Pomper , et al. July 15, 2
2014-07-15
Imaging infection with compounds that bind to thymidine kinase
Grant 8,691,186 - Pomper , et al. April 8, 2
2014-04-08
Collagen Mimetic Peptides For Targeting Collagen Strands For In Vitro And In Vivo Imaging And Therapeutic Use
App 20130164220 - Yu; Michael S. ;   et al.
2013-06-27
Imaging Infection With Compounds That Bind To Thymidine Kinase
App 20130064767 - Pomper; Martin G. ;   et al.
2013-03-14
Imaging infection with compounds that bind to thymidine kinase
Grant 8,273,326 - Pomper , et al. September 25, 2
2012-09-25
Tspo-targeting Compounds And Uses Thereof
App 20110212025 - Pomper; Martin G. ;   et al.
2011-09-01
Prostate Specific Membrane Antigen (psma) Targeted Nanoparticles For Therapy Of Prostate Cancer
App 20110200677 - Chandran; Sachin S. ;   et al.
2011-08-18
Imaging And Therapy Of Virus-associated Tumors
App 20110176998 - Pomper; Martin G. ;   et al.
2011-07-21
Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor
App 20100034741 - Pomper; Martin G. ;   et al.
2010-02-11
Imaging Infection With Compounds That Bind to Thymidine Kinase
App 20090010844 - Pomper; Martin G. ;   et al.
2009-01-08
Imaging agents and methods of imaging alpha7-nicotinic cholinergic receptor
App 20050129610 - Pomper, Martin G. ;   et al.
2005-06-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed